Carbidopa/levodopa/entacapona (Spanish Wikipedia)

Analysis of information sources in references of the Wikipedia article "Carbidopa/levodopa/entacapona" in Spanish language version.

refsWebsite

Global rank Spanish rank

2^nd place

2^nd place

57^th place

3^rd place

2books.google.com

3^rd place

7^th place

49^th place

100^th place

4^th place

4^th place

5^th place

10^th place

1neurotransmitter.net

low place

low place

399^th place

648^th place

447^th place

668^th place

low place

low place

books.google.com

MD, Osama O. Zaidat; PhD, J. Douglas Miles, MD; MD, Alan J. Lerner (10 de junio de 2020). El Pequeño Libro Negro de la Neurología. Elsevier Health Sciences. ISBN 978-84-9113-818-1. Consultado el 4 de febrero de 2022.
Leikin, Jerrold B.; Paloucek, Frank P. (2007). Poisoning and toxicology handbook (4th edición). Informa Health Care. p. 610. ISBN 978-1-4200-4479-9.

doi.org

dx.doi.org

Stocchi, Fabrizio; Hsu, Ann; Khanna, Sarita; Ellenbogen, Aaron; Mahler, Andreas; Liang, Grace; Dillmann, Ulrich; Rubens, Robert et al. (2014-12). «Comparison of IPX066 with carbidopa–levodopa plus entacapone in advanced PD patients». Parkinsonism & Related Disorders 20 (12): 1335-1340. ISSN 1353-8020. doi:10.1016/j.parkreldis.2014.08.004. Consultado el 4 de febrero de 2022.
Hsu, Ann; Yao, Hsuan‐Ming; Gupta, Suneel; Modi, Nishit B. (20 de mayo de 2015). «Comparison of the pharmacokinetics of an oral extended‐release capsule formulation of carbidopa‐levodopa (IPX066) with immediate‐release carbidopa‐levodopa (Sinemet®), sustained‐release carbidopa‐levodopa (Sinemet®CR), and carbidopa‐levodopa‐entacapone (Stalevo®)». The Journal of Clinical Pharmacology 55 (9): 995-1003. ISSN 0091-2700. doi:10.1002/jcph.514. Consultado el 4 de febrero de 2022.

drugs.com

Stalevo patient advice including side effects - Drugs.com Retrieved 2010-4-2

epocrates.com

online.epocrates.com

Stalevo Drug Interactions - ePocrates Online Retrieved 2010-4-2

fda.gov

Stalevo (entacapone/carbidopa/levodopa): Ongoing Safety Review Retrieved on 2010-4-2

issn.org

portal.issn.org

Stocchi, Fabrizio; Hsu, Ann; Khanna, Sarita; Ellenbogen, Aaron; Mahler, Andreas; Liang, Grace; Dillmann, Ulrich; Rubens, Robert et al. (2014-12). «Comparison of IPX066 with carbidopa–levodopa plus entacapone in advanced PD patients». Parkinsonism & Related Disorders 20 (12): 1335-1340. ISSN 1353-8020. doi:10.1016/j.parkreldis.2014.08.004. Consultado el 4 de febrero de 2022.
Hsu, Ann; Yao, Hsuan‐Ming; Gupta, Suneel; Modi, Nishit B. (20 de mayo de 2015). «Comparison of the pharmacokinetics of an oral extended‐release capsule formulation of carbidopa‐levodopa (IPX066) with immediate‐release carbidopa‐levodopa (Sinemet®), sustained‐release carbidopa‐levodopa (Sinemet®CR), and carbidopa‐levodopa‐entacapone (Stalevo®)». The Journal of Clinical Pharmacology 55 (9): 995-1003. ISSN 0091-2700. doi:10.1002/jcph.514. Consultado el 4 de febrero de 2022.

neurotransmitter.net

Drug Reference for FDA Approved Parkinson's Disease Drugs Retrieved 2010-4-1

nih.gov

dailymed.nlm.nih.gov

«Stalevo- carbidopa, levodopa, and entacapone tablet, film coated». DailyMed. 7 de enero de 2020. Consultado el 19 de mayo de 2020.

reuters.com

FDA evaluating cancer link in Parkinson's drug Retrieved 2010-3-31
FDA to review heart risks of Parkinson's drug Retrieved 2010-8-20

worldcat.org

Cheryl, Poulopoulos, Markos Waters,. Carbidopa/levodopa/entacapone: the evidence for its place in the treatment of Parkinson's disease. Dove Medical Press. OCLC 676927586. Consultado el 4 de febrero de 2022.